Reactions Weekly

, Volume 1697, Issue 1, pp 213–213 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Various toxicities: 6 case reports
Case report
  • 10 Downloads

Reference

  1. Richter MD, et al. Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience. Arthritis and Rheumatology 70: 356-360, No. 3, Mar 2018. Available from: URL: https://doi.org/10.1002/art.40397 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations